• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·BRVE
Share

Braveheart Bio, Inc. Stocks

$ 26.74Last Updated 04.09.2026

Issuer Rating

Performance

Very poor

Risk

Considerable

Recommendation

Sell

Market Cap

$ 1.89B

$ 26.74
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

09.08.2026 21:00

Robots Backed by DeepSeek Investments and a Wave of Biotech IPOs: Key Takeaways on IPOs Through August 9

06.08.2026 15:00

Braveheart Bio IPO: Shares in the cardiovascular drug developer are now available

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.09.2026 18:02

The wave of attacks by Iran and the U.S. on ships near the Strait of Hormuz has reached its peak since the start of the war

09.09.2026 17:04

Novartis's failed trials sent shares of mid-cap biotech company Dyne plummeting. The two companies have similar drugs.

09.09.2026 16:15

The dollar has fallen to a seven-month low. What is driving it down?

09.09.2026 15:41

Morning in New York: Brent Puts Investors to the Test

09.09.2026 14:40

U.S. authorities criticized Ford for its business dealings with China. Its stock fell 4%.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026